Elongation kinetics of polyglutamine peptide fibrils: a quartz crystal microbalance with dissipation study
- PMID: 22459263
- PMCID: PMC3572748
- DOI: 10.1016/j.jmb.2012.03.017
Elongation kinetics of polyglutamine peptide fibrils: a quartz crystal microbalance with dissipation study
Abstract
Abnormally expanded polyglutamine domains in proteins are associated with several neurodegenerative diseases, including Huntington's disease. Expansion of the polyglutamine (polyQ) domain facilitates aggregation of the affected protein, and several studies directly link aggregation to neurotoxicity. Studies of synthetic polyQ peptides have contributed substantially to our understanding of the mechanism of aggregation. In this report, polyQ fibrils were immobilized onto a sensor, and their elongation by polyQ peptides of various length and conformation was examined using quartz crystal microbalance with dissipation monitoring (QCM-D). The rate of elongation increased as the peptide length increased from 8 to 24 glutamines (Q8, Q20, and Q24). Monomer conformation affected elongation rates: insertion of a β-turn template d-Pro-Gly in the center of the peptide increased elongation rates several-fold, while insertion of Pro-Pro dramatically slowed elongation. Dissipation measurements of the QCM-D provided qualitative information about mechanical properties of the elongating fibrils. These data showed clear differences in the characteristics of the elongating aggregates, depending on the specific identity of the associating polyQ peptide. Elongation rates were sensitive to the pH and ionic strength of the buffer. Comparison of QCM-D data with those obtained by optical waveguide lightmode spectroscopy revealed that very little water was associated with the elongation of fibrils by the peptide containing d-Pro-Gly, but a significant amount of water was associated when the fibrils were elongated by Q20. Together, the data indicate that elongation of polyQ fibrils can occur without full consolidation to the fibril structure, resulting in variations to the aggregate structure during elongation.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
Influence of the protein context on the polyglutamine length-dependent elongation of amyloid fibrils.Biochim Biophys Acta. 2015 Mar;1854(3):239-48. doi: 10.1016/j.bbapap.2014.12.002. Epub 2014 Dec 6. Biochim Biophys Acta. 2015. PMID: 25489872
-
Examining polyglutamine peptide length: a connection between collapsed conformations and increased aggregation.J Mol Biol. 2009 Nov 6;393(4):978-92. doi: 10.1016/j.jmb.2009.08.034. Epub 2009 Aug 20. J Mol Biol. 2009. PMID: 19699209 Free PMC article.
-
Aggregation kinetics of interrupted polyglutamine peptides.J Mol Biol. 2011 Sep 23;412(3):505-19. doi: 10.1016/j.jmb.2011.07.003. Epub 2011 Jul 29. J Mol Biol. 2011. PMID: 21821045 Free PMC article.
-
Conformational changes and aggregation of expanded polyglutamine proteins as therapeutic targets of the polyglutamine diseases: exposed beta-sheet hypothesis.Curr Pharm Des. 2008;14(30):3267-79. doi: 10.2174/138161208786404164. Curr Pharm Des. 2008. PMID: 19075705 Review.
-
Towards the treatment of polyglutamine diseases: the modulatory role of protein context.Curr Med Chem. 2010;17(27):3058-68. doi: 10.2174/092986710791959800. Curr Med Chem. 2010. PMID: 20629626 Review.
Cited by
-
Backbone Engineering within a Latent β-Hairpin Structure to Design Inhibitors of Polyglutamine Amyloid Formation.J Mol Biol. 2017 Jan 20;429(2):308-323. doi: 10.1016/j.jmb.2016.12.010. Epub 2016 Dec 13. J Mol Biol. 2017. PMID: 27986569 Free PMC article.
-
Pathologic polyglutamine aggregation begins with a self-poisoning polymer crystal.Elife. 2023 Nov 3;12:RP86939. doi: 10.7554/eLife.86939. Elife. 2023. PMID: 37921648 Free PMC article.
-
An Analysis of Biomolecular Force Fields for Simulations of Polyglutamine in Solution.Biophys J. 2015 Sep 1;109(5):1009-18. doi: 10.1016/j.bpj.2015.07.018. Biophys J. 2015. PMID: 26331258 Free PMC article.
-
A coarse-grained model for polyglutamine aggregation modulated by amphipathic flanking sequences.Biophys J. 2014 Sep 2;107(5):1226-1235. doi: 10.1016/j.bpj.2014.07.019. Biophys J. 2014. PMID: 25185558 Free PMC article.
-
Live-cell super-resolution microscopy reveals a primary role for diffusion in polyglutamine-driven aggresome assembly.J Biol Chem. 2019 Jan 4;294(1):257-268. doi: 10.1074/jbc.RA118.003500. Epub 2018 Nov 6. J Biol Chem. 2019. PMID: 30401748 Free PMC article.
References
-
- Bates G. Huntingtin aggregation and toxicity in Huntington's disease. Lancet. 2003;361:1642–1644. - PubMed
-
- Orr HT. Beyond the Qs in the polyglutamine diseases. Genes Dev. 2001;15:925–932. - PubMed
-
- Wanker EE. Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations. Biol. Chem. 2000;381:937–942. - PubMed
-
- Albrecht M, Golatta M, Wullner U, Lengauer T. Structural and functional analysis of ataxin-2 and ataxin-3. Eur. J. Biochem. 2004;271:3155–3170. - PubMed
-
- Gusella JF, MacDonald ME. Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat. Rev. Neurosci. 2000;1:109–115. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
